1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc
XNAS: KROS
11.02 0.03 (0.27%)
516.6K
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Keros Therapeutics Inc - KROS - stock price prediction, stock price target, analyst ratings from 9 analysts

Keros Therapeutics Inc has a share price target of US$ 23, revenue growth forecast of -98.7%, and profit growth estimate of -254.2% for FY26, based on top 9 analyst calls.